David Nakasone | IR |
Brett Monia | Founder, CEO & Director |
Elizabeth Hougen | EVP, Finance & CFO |
Richard Geary | EVP & Chief Development Officer |
Eric Swayze | EVP, Research |
Onaiza Cadoret-Manier | EVP & Chief Corporate Development & Commercial Officer |
Jason Gerberry | Bank of America Merrill Lynch |
Luca Issi | RBC Capital Markets |
Brendan Smith | Cowen and Company |
Yanan Zhu | Wells Fargo Securities |
Alexander Thompson | Stifel, Nicolaus & Company |
Yale Jen | Laidlaw & Company |
Jessica Fye | JPMorgan Chase & Co. |
Mani Foroohar | SVB Leerink |
Myles Minter | William Blair & Company |
Esther Rajavelu | UBS |
David Lebowitz | Morgan Stanley |
Good morning, and welcome to Ionis Pharmaceuticals Second Quarter 2021 Financial Results Conference Call.
As a reminder, this call is being recorded. At this time, I would like to turn the call over to Dave Nakasone, Investor Relations to lead off the call. Please begin.
Thank you, Debbie.